November 6, 2006
Today Adolor Corp. announced receipt of an approvable letter from the FDA requesting 12-month safety data that includes an analysis of any cardiovascular related adverse events. The application was for Entereg, indicated for the management of postoperative ileus. Share this:
The Ryan White CARE Act is the backbone of not only care, but of access to life-saving medications that have made such a dramatic change in the AIDS epidemic by changing mortality rates. The access to these medications is through … Continue reading →